| Application no. and date | 16793229.2 (espacenet) (Federated) (European Patent Register), 20160505 | | Patent/reg. no. and date | DK/EP 3294345, 20231018 | | Publication date | 20180321 | | Priority no. and date | US 201562158789 P, 20150508, US 201662300171 P, 20160226 | | EP pub. no. and date |
EP 3294345 20180321 | | Effective date | | | Applicant/owner | BioMarin Pharmaceutical Inc., 105 Digital Drive
Novato, CA 94949, US | | Applicant ref. no. | 1682419 | | Inventor | OKHAMAFE, Augustus, O., 5310 Crystal Ranch Drive
Concord, CA 94521, US,
MOSHASHAEE, Saeed, 1869 Las Gallinas Avenue
San Rafael, CA 94903, US,
O'NEILL, Charles, A., P.O. Box 218
Vineburg, CA 95487, US,
LESTER, Thomas, W., 4175 Somerset Ave
Castro Valley, CA 94546-3552, US | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Opponent | | | IPC Class | A61K 48/00 (2006.01) , A61K 49/14 (2006.01) , A61K 9/08 (2006.01) , A61P 25/28 (2006.01) | | Title | TPP1-FORMULERINGER OG FREMGANGSMÅDER TIL BEHANDLING AF CLN2-SYGDOM | | Int. application no. | US2016031074 | | Int. publication no. | WO2016182862 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
